- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7084 - Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
Patent holdings for IPC class A61K 31/7084
Total number of patents in this class: 671
10-year publication summary
|
31
|
50
|
67
|
75
|
80
|
83
|
101
|
96
|
55
|
14
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Santen Pharmaceutical Co., Ltd. | 649 |
29 |
| Nuvamid SA | 54 |
18 |
| Institute of Organic Chemistry and Biochemistry ASCR,V.V.I. | 36 |
14 |
| The Board of Regents of the University of Texas System | 2043 |
14 |
| Eisai R&D Management Co., Ltd. | 1304 |
14 |
| Hoboomlife Bio-Technology (Shenzhen) Co., Ltd. | 35 |
14 |
| Takeda Pharmaceutical Company Limited | 2961 |
12 |
| Lonza Sales AG | 112 |
9 |
| Janssen Biotech, Inc. | 1347 |
8 |
| Innate Tumor Immunity, Inc. | 43 |
8 |
| Hangzhou Xingao Biotechnology Co. Ltd | 17 |
8 |
| Merck Sharp & Dohme LLC | 3689 |
8 |
| Merck Sharp & Dohme Corp. | 2247 |
7 |
| Astex Pharmaceuticals, Inc. | 29 |
7 |
| Immunesensor Therapeutics, Inc. | 30 |
7 |
| Centre National de La Recherche Scientifique | 9632 |
6 |
| Glaxosmithkline Intellectual Property Development Limited | 723 |
6 |
| Board of Regents, The University of Texas System | 5370 |
6 |
| Codiak Biosciences, Inc. | 57 |
6 |
| F-star Therapeutics, Inc | 13 |
6 |
| Other owners | 464 |